136 related articles for article (PubMed ID: 15458897)
1. Regression of low-grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13 genotype.
Sastre-Garau X; Cartier I; Jourdan-Da Silva N; De Crémoux P; Lepage V; Charron D
Obstet Gynecol; 2004 Oct; 104(4):751-5. PubMed ID: 15458897
[TBL] [Abstract][Full Text] [Related]
2. Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese.
Chan PK; Cheung TH; Lin CK; Siu SS; Yim SF; Lo KW; Cheung JL; Tam AO; Tang JW
J Med Virol; 2007 Jul; 79(7):970-6. PubMed ID: 17516530
[TBL] [Abstract][Full Text] [Related]
3. HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study.
Matsumoto K; Maeda H; Oki A; Takatsuka N; Yasugi T; Furuta R; Hirata R; Mitsuhashi A; Fujii T; Hirai Y; Iwasaka T; Yaegashi N; Watanabe Y; Nagai Y; Kitagawa T; Yoshikawa H;
Int J Gynecol Cancer; 2012 Mar; 22(3):471-8. PubMed ID: 22391763
[TBL] [Abstract][Full Text] [Related]
4. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?
Matsumoto K; Maeda H; Oki A; Takatsuka N; Yasugi T; Furuta R; Hirata R; Mitsuhashi A; Kawana K; Fujii T; Iwata T; Hirai Y; Yokoyama M; Yaegashi N; Watanabe Y; Nagai Y; Yoshikawa H;
Cancer Sci; 2015 Oct; 106(10):1448-54. PubMed ID: 26235935
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles.
Odunsi K; Terry G; Ho L; Bell J; Cuzick J; Ganesan TS
Int J Cancer; 1996 Sep; 67(5):595-602. PubMed ID: 8782644
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.
Trimble CL; Piantadosi S; Gravitt P; Ronnett B; Pizer E; Elko A; Wilgus B; Yutzy W; Daniel R; Shah K; Peng S; Hung C; Roden R; Wu TC; Pardoll D
Clin Cancer Res; 2005 Jul; 11(13):4717-23. PubMed ID: 16000566
[TBL] [Abstract][Full Text] [Related]
8. Association of human leukocyte antigen and T cell message with human papillomavirus 16-positive cervical neoplasia in Japanese women.
Saito M; Okubo M; Hirata R; Takeda S; Maeda H
Int J Gynecol Cancer; 2007; 17(6):1314-21. PubMed ID: 17433060
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
[TBL] [Abstract][Full Text] [Related]
10. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma.
Apple RJ; Becker TM; Wheeler CM; Erlich HA
J Natl Cancer Inst; 1995 Mar; 87(6):427-36. PubMed ID: 7861462
[TBL] [Abstract][Full Text] [Related]
11. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women.
Sanjeevi CB; Hjelmström P; Hallmans G; Wiklund F; Lenner P; Angström T; Dillner J; Lernmark A
Int J Cancer; 1996 Nov; 68(4):409-14. PubMed ID: 8945607
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.
Hildesheim A; Schiffman M; Scott DR; Marti D; Kissner T; Sherman ME; Glass AG; Manos MM; Lorincz AT; Kurman RJ; Buckland J; Rush BB; Carrington M
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1035-41. PubMed ID: 9829713
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia.
Kawase K; Taguchi A; Ishizaka A; Lin J; Ueno T; Yoshimoto D; Eguchi S; Mori S; Sone K; Mori M; Yonekura S; Hanazawa T; Maeda D; Kukimoto I; Mano H; Osuga Y; Kawana K; Kawazu M
HLA; 2024 Jun; 103(6):e15509. PubMed ID: 38837741
[TBL] [Abstract][Full Text] [Related]
14. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.
Sastre-Garau X; Loste MN; Vincent-Salomon A; Favre M; Mouret E; de la Rochefordiere A; Durand JC; Tartour E; Lepage V; Charron D
Int J Cancer; 1996 Jun; 69(3):159-64. PubMed ID: 8682580
[TBL] [Abstract][Full Text] [Related]
15. Association between human leukocyte antigen class II alleles and human papillomavirus-mediated cervical cancer in Indian women.
Kohaar I; Hussain S; Thakur N; Tiwari P; Nasare V; Batra S; Singh V; Bhambani S; Das BC; Sarkar DP; Bharadwaj M
Hum Immunol; 2009 Apr; 70(4):222-9. PubMed ID: 19272325
[TBL] [Abstract][Full Text] [Related]
16. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica.
Wang SS; Wheeler CM; Hildesheim A; Schiffman M; Herrero R; Bratti MC; Sherman ME; Alfaro M; Hutchinson ML; Morales J; Lorincz A; Burk RD; Carrington M; Erlich HA; Apple RJ
J Infect Dis; 2001 Nov; 184(10):1310-4. PubMed ID: 11679920
[TBL] [Abstract][Full Text] [Related]
17. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
18. Association of DRB1 and DQB1 HLA class II polymorphisms in high-grade and neoplastic cervical lesions of women from Argentina.
Eiguchi K; Tatti S; Alonio LV; González JV; Leirós GJ; Fleider L; Vighi S; Padros K; Raimondi E; Teyssié A; Picconi MA
J Low Genit Tract Dis; 2008 Oct; 12(4):262-8. PubMed ID: 18820539
[TBL] [Abstract][Full Text] [Related]
19. Selected class I and class II HLA alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia.
Ades S; Koushik A; Duarte-Franco E; Mansour N; Arseneau J; Provencher D; Gilbert L; Gotlieb W; Ferenczy A; Coutlée F; Roger M; Franco EL;
Int J Cancer; 2008 Jun; 122(12):2820-6. PubMed ID: 18351579
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
